MarginsXMarginsX
Home › Markets › Industrials › CIRC

Circle8 Group Inc. (CIRC)

CIRC trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.1702
-7.30% on the day
Market cap
$20.0M
Nano cap
Revenue · 2025
$435.9M
-1.5% on 2024
Net income · 2025
-$59.4M
-13.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1605888/000160588826000017/0001605888-26-000017-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCIRC on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2024
SEC CIK0001605888
SEC industry codeServices-Help Supply Services
Incorporated inDE

Financials · 2025

LineValue
Revenue$435.9M
Net income-$59.4M
Operating income-$50.2M
Net margin-13.6%
Operating margin-11.5%
Revenue growth-1.5%
Cash$81K
Total assets$113.2M
P/E (computed)Net income was not positive
P/S (computed)0.0×

Warning signs

Cash runway
10.0 months
$19.3M cash at June 30, 2026
Share count, 1 year
+96.0%
2025-08-08 to 2026-08-14 · +32855.1% over 3 years
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
-$309K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Circle8 has concluded that there is substantial doubt about its ability to continue as a going concern for at least one year from the date of issuance of its unaudited condensed consolidated financial statements."
10-Q 2026-08-19
Cash and burn$19.3M cash; operating cash flow -$5.8M a quarter.Report 2026-06-30
Shares outstanding114,406,923 (2026-08-14); 58,375,488 a year earlier; 13,886,379 three years earlier. 3y figure adjusted for split (1-for-40 overall).Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-23
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-08-19
AuditorRBSM LLP, LAS VEGAS, Nevada, United StatesPCAOB Form AP 2026-04-16
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-17
Insider trades, 12 monthsBought $0, sold $309K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$319.8M-$86.4M-$3.8M$19.3M$568.4M$799.9M10-Q 2026-08-19
Q1 2026
2026-03-31
$249.9M-$30.7M-$9.9M$24.1M$513.2M$583.0M10-Q 2026-06-22
Q4 2025
2025-12-31
$120.0M-$27.1M-$8.2M$81K$84.7M$435.9M10-K 2026-04-15
Q3 2025
2025-09-30
$110.1M-$10.8M-$1.3M$83K$76.4M$445.4M10-Q 2025-11-14
Q2 2025
2025-06-30
$102.9M-$10.7M-$9.5M$375K$75.4M$443.1M10-Q 2026-08-19
Q1 2025
2025-03-31
$102.8M-$10.7M$14.6M$1.5M$66.9M$444.8M10-Q 2026-06-22
Q4 2024
2024-12-31
$129.5M-$68.7M-$426K$679K$80.6M$442.6M10-K 2026-04-15
Q3 2024
2024-09-30
$107.8M-$7.0M-$1.3M$1.4M$80.8M$429.3M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B72026-10-07
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-19
Latest current report8-K2026-10-23
Latest proxy
PROXY STATEMENT
DEF 14A2026-11-03

Source: SEC EDGAR submissions feed, 319 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.2%
1 month-49.0%
3 months-72.9%
Year to date-86.2%
1 year-93.0%
From 52-week high-95.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
BNGOBionano Genomics Inc.$0.9400-6.00%$13.1M
EYPTEyePoint Inc.$0.3076+0.52%$35.0M
PRPOPrecipio Inc.$19.96-9.81%$35.8M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
ASTCAstrotech Corporation (DE)$3.76-10.48%$8.0M
SEERSeer Inc.$1.48-5.73%$82.6M
QTRXQuanterix Corporation$2.84-3.07%$134.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier